News
GSK PLC GSK shares slid 2.06% to £14.50 Wednesday, on what proved to be an all-around positive trading session for the stock ...
It’s been years since the Cannes Lions International Festival of Creativity awarded its top prize to a traditional ...
21h
Zacks Investment Research on MSNGSK Stock Rises Almost 22% in 6 Months: Time to Buy, Sell or Hold?GSK GSK stock has risen 21.5% in the past six months. The consistently strong performance of the Specialty Medicines unit, ...
The debate between CAR T-cell therapy and bispecific antibodies is not a rivalry but a question of sequencing, ...
GSK plc (NYSE:GSK) is one of the 12 best healthcare stocks to buy now. On June 12, the company announced licensing its ...
2d
Zacks Investment Research on MSNEMA Accepts GSK's Filing for Expanded Use of RSV Vaccine ArexvyGSK plc GSK announced that the European Medicines Agency (EMA) has accepted the regulatory application seeking approval to ...
GSK plc (LSE/NYSE: GSK) today announced the launch of the Linked by Lupus: Optimal Care Initiative to help support individuals impacted with lupus, particularly systemic lupus erythematosus (SLE) and ...
Sage Therapeutics Inc. has found itself a buyer that bested the unsolicited acquisition offer a few months ago from fellow ...
Recent collaborations highlight a growing interest in building a multiomics-based understanding of health and disease.
GSK PLC GSK shares dropped 2.45% to £15.12 Friday, on what proved to be an all-around poor trading session for the stock ...
GSK has applied to the European Medicines Agency to expand use of its respiratory syncytial virus (RSV) vaccine to adults ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results